Drug intelligence / Profile preview

enterovirus type 71 inactivated vaccine

Development stage
Unknown
Lead developer
Shenzhen Mellow Hope Pharm Industrial
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Enterovirus type 71 inactivated vaccine is a **prophylactic inactivated viral vaccine** intended to prevent hand, foot and mouth disease caused by enterovirus A71 infection. It induces EV71-specific neutralizing immune responses after intramuscular administration and does not protect against HFMD caused by other enteroviruses such as coxsackievirus A16. The Mellow Hope product listing specifically describes a human-diploid-cell EV71 inactivated vaccine supplied as a liquid injection; this presentation is consistent with the human-diploid-cell product marketed as EntroVac by the Institute of Medical Biology, Chinese Academy of Medical Sciences. ([english.mellowhope.com](https://english.mellowhope.com/product-en/96.html))

Other names
EV71 inactivated vaccineEV-71 inactivated vaccineEV 71 inactivated vaccineenterovirus A71 inactivated vaccine肠道病毒71型灭活疫苗

Beyond the preview

Go deeper on enterovirus type 71 inactivated vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on enterovirus type 71 inactivated vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call